256 related articles for article (PubMed ID: 37835513)
1. Differential Expression of NEK Kinase Family Members in Esophageal Adenocarcinoma and Barrett's Esophagus.
Chen L; Ballout F; Lu H; Hu T; Zhu S; Chen Z; Peng D
Cancers (Basel); 2023 Sep; 15(19):. PubMed ID: 37835513
[TBL] [Abstract][Full Text] [Related]
2. Integrative Analysis of the Expression Levels and Prognostic Values for NEK Family Members in Breast Cancer.
Gao WL; Niu L; Chen WL; Zhang YQ; Huang WH
Front Genet; 2022; 13():798170. PubMed ID: 35368696
[No Abstract] [Full Text] [Related]
3. Expression of the NEK family in normal and cancer tissue: an immunohistochemical study.
Melo-Hanchuk TD; Martins MB; Cunha LL; Soares FA; Ward LS; Vassallo J; Kobarg J
BMC Cancer; 2020 Jan; 20(1):23. PubMed ID: 31906878
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value and therapeutic potential of NEK family in stomach adenocarcinoma.
Zhou X; Nie H; Wang C; Yu X; Yang X; He X; Ou C
J Cancer; 2024; 15(10):3154-3172. PubMed ID: 38706902
[TBL] [Abstract][Full Text] [Related]
5. The NEK family of serine/threonine kinases as a biomarker for cancer.
Panchal NK; Evan Prince S
Clin Exp Med; 2023 Feb; 23(1):17-30. PubMed ID: 35037094
[TBL] [Abstract][Full Text] [Related]
6. Expression profiles of cancer stem cell markers: CD133, CD44, Musashi-1 and EpCAM in the cardiac mucosa-Barrett's esophagus-early esophageal adenocarcinoma-advanced esophageal adenocarcinoma sequence.
Mokrowiecka A; Veits L; Falkeis C; Musial J; Kordek R; Lochowski M; Kozak J; Wierzchniewska-Lawska A; Vieth M; Malecka-Panas E
Pathol Res Pract; 2017 Mar; 213(3):205-209. PubMed ID: 28216140
[TBL] [Abstract][Full Text] [Related]
7. Esophageal Adenocarcinoma and Its Rare Association with Barrett's Esophagus in Henan, China.
Liu S; Dai JY; Yao L; Li X; Reid B; Self S; Ma J; Chang Y; Feng S; Tapsoba Jde D; Sun X; Sun X
PLoS One; 2014; 9(10):e110348. PubMed ID: 25333822
[TBL] [Abstract][Full Text] [Related]
8. Chronic Obstructive Pulmonary Disease and the Risk of Esophagitis, Barrett's Esophagus, and Esophageal Adenocarcinoma: A Primary Care Case-Control Study.
Menon S; Nightingale P; Trudgill N
J Clin Gastroenterol; 2019; 53(10):e451-e455. PubMed ID: 31008868
[TBL] [Abstract][Full Text] [Related]
9. BMP4 Signaling Is Able to Induce an Epithelial-Mesenchymal Transition-Like Phenotype in Barrett's Esophagus and Esophageal Adenocarcinoma through Induction of SNAIL2.
Kestens C; Siersema PD; Offerhaus GJ; van Baal JW
PLoS One; 2016; 11(5):e0155754. PubMed ID: 27191723
[TBL] [Abstract][Full Text] [Related]
10. Bile acid exposure up-regulates tuberous sclerosis complex 1/mammalian target of rapamycin pathway in Barrett's-associated esophageal adenocarcinoma.
Yen CJ; Izzo JG; Lee DF; Guha S; Wei Y; Wu TT; Chen CT; Kuo HP; Hsu JM; Sun HL; Chou CK; Buttar NS; Wang KK; Huang P; Ajani J; Hung MC
Cancer Res; 2008 Apr; 68(8):2632-40. PubMed ID: 18413730
[TBL] [Abstract][Full Text] [Related]
11. Hypermethylation of the AKAP12 promoter is a biomarker of Barrett's-associated esophageal neoplastic progression.
Jin Z; Hamilton JP; Yang J; Mori Y; Olaru A; Sato F; Ito T; Kan T; Cheng Y; Paun B; David S; Beer DG; Agarwal R; Abraham JM; Meltzer SJ
Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):111-7. PubMed ID: 18199717
[TBL] [Abstract][Full Text] [Related]
12. Cell cycle regulation by the NEK family of protein kinases.
Fry AM; O'Regan L; Sabir SR; Bayliss R
J Cell Sci; 2012 Oct; 125(Pt 19):4423-33. PubMed ID: 23132929
[TBL] [Abstract][Full Text] [Related]
13. Gene Expression in Barrett's Esophagus Cell Lines Resemble Esophageal Squamous Cell Carcinoma Instead of Esophageal Adenocarcinoma.
Panda A; Bhanot G; Ganesan S; Bajpai M
Cancers (Basel); 2021 Nov; 13(23):. PubMed ID: 34885081
[TBL] [Abstract][Full Text] [Related]
14. Biomarker identification and trans-regulatory network analyses in esophageal adenocarcinoma and Barrett's esophagus.
Lv J; Guo L; Wang JH; Yan YZ; Zhang J; Wang YY; Yu Y; Huang YF; Zhao HP
World J Gastroenterol; 2019 Jan; 25(2):233-244. PubMed ID: 30670912
[TBL] [Abstract][Full Text] [Related]
15. Identification of the putative intestinal stem cell marker doublecortin and CaM kinase-like-1 in Barrett's esophagus and esophageal adenocarcinoma.
Vega KJ; May R; Sureban SM; Lightfoot SA; Qu D; Reed A; Weygant N; Ramanujam R; Souza R; Madhoun M; Whorton J; Anant S; Meltzer SJ; Houchen CW
J Gastroenterol Hepatol; 2012 Apr; 27(4):773-80. PubMed ID: 21916995
[TBL] [Abstract][Full Text] [Related]
16. Decoding common genetic alterations between Barrett's esophagus and esophageal adenocarcinoma: A bioinformatics analysis.
Jalali P; Yaghoobi A; Rezaee M; Zabihi MR; Piroozkhah M; Aliyari S; Salehi Z
Heliyon; 2024 May; 10(10):e31194. PubMed ID: 38803922
[TBL] [Abstract][Full Text] [Related]
17. Novel Aberrations Uncovered in Barrett's Esophagus and Esophageal Adenocarcinoma Using Whole Transcriptome Sequencing.
Maag JLV; Fisher OM; Levert-Mignon A; Kaczorowski DC; Thomas ML; Hussey DJ; Watson DI; Wettstein A; Bobryshev YV; Edwards M; Dinger ME; Lord RV
Mol Cancer Res; 2017 Nov; 15(11):1558-1569. PubMed ID: 28751461
[TBL] [Abstract][Full Text] [Related]
18. Trefoil factor 1 inhibits the development of esophageal adenocarcinoma from Barrett's epithelium.
Hasebe K; Yamazaki K; Yamaguchi J; Kokuryo T; Yokoyama Y; Miyata K; Fukaya M; Nagino M; Ebata T
Lab Invest; 2022 Aug; 102(8):885-895. PubMed ID: 35279702
[TBL] [Abstract][Full Text] [Related]
19. Local Synthesis of Pepsin in Barrett's Esophagus and the Role of Pepsin in Esophageal Adenocarcinoma.
Samuels T; Hoekzema C; Gould J; Goldblatt M; Frelich M; Bosler M; Lee SH; Johnston N
Ann Otol Rhinol Laryngol; 2015 Nov; 124(11):893-902. PubMed ID: 26077392
[TBL] [Abstract][Full Text] [Related]
20. Laryngopharyngeal reflux symptoms better predict the presence of esophageal adenocarcinoma than typical gastroesophageal reflux symptoms.
Reavis KM; Morris CD; Gopal DV; Hunter JG; Jobe BA
Ann Surg; 2004 Jun; 239(6):849-56; discussion 856-8. PubMed ID: 15166964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]